The estimated Net Worth of Jonathan P Graham is at least $31.3 Million dollars as of 8 November 2023. Mr. Graham owns over 10,000 units of AMGEN stock worth over $9,265,178 and over the last 18 years he sold AMGN stock worth over $14,766,784. In addition, he makes $7,239,970 as Senior Vice President, General Counsel und Secretary at AMGEN.
Jonathan has made over 20 trades of the AMGEN stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of AMGN stock worth $2,728,100 on 8 November 2023.
The largest trade he's ever made was exercising 185,620 units of AMGEN stock on 14 May 2015 worth over $6,288,806. On average, Jonathan trades about 3,701 units every 41 days since 2006. As of 8 November 2023 he still owns at least 28,078 units of AMGEN stock.
You can see the complete history of Mr. Graham stock trades at the bottom of the page.
Jonathan P. Graham serves as Senior Vice President, General Counsel, Secretary of the Company. Mr. Graham joined the Company in 2015. From 2015 to 2019, Mr. Graham was Senior Vice President, General Counsel and Secretary. Prior to joining Amgen, from 2006 to 2015, Mr. Graham was Senior Vice President and General Counsel at Danaher Corporation. From 2004 to 2006, Mr. Graham was Vice President, Litigation and Legal Policy at General Electric Company (GE). Prior to GE, Mr. Graham was a partner at Williams & Connolly LLP.
As the Senior Vice President, General Counsel und Secretary of AMGEN, the total compensation of Jonathan Graham at AMGEN is $7,239,970. There are 1 executives at AMGEN getting paid more, with Robert Bradway having the highest compensation of $19,612,800.
Jonathan Graham is 59, he's been the Senior Vice President, General Counsel und Secretary of AMGEN since 2015. There are 12 older and 13 younger executives at AMGEN. The oldest executive at AMGEN Inc. is Fred Hassan, 74, who is the Independent Director.
Jonathan's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320-1799.
Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer und Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: